Mucopolysaccharidosis (MPS) Treatment Market Poised for Growth, Expected to Reach $3.19 Billion by 2028
Mucopolysaccharidosis (MPS) Treatment Global Market Report 2024 – Market Size, Trends, And Market Forecast 2024-2033
The Business Research Company’s Mucopolysaccharidosis (MPS) Treatment Global Market Report 2024 – Market Size, Trends, And Market Forecast 2024-2033
LONDON, GREATER LONDON, UK, July 8, 2024 /EINPresswire.com/ -- The mucopolysaccharidosis treatment market has experienced robust growth, projected to increase from $2.2 billion in 2023 to $2.38 billion in 2024, at a compound annual growth rate (CAGR) of 8.5%. It will grow to $3.19 billion in 2028 at a compound annual growth rate (CAGR) of 7.5%. This growth in recent years can be attributed to advancements such as enzyme replacement therapy (ERT), improved diagnostic tools, advocacy and awareness campaigns, gene therapy developments, and enhancements in healthcare infrastructure.
Rising Demand for Treatment Options Drives Market Growth
The increasing prevalence of various forms of mucopolysaccharidosis, where complex carbohydrates accumulate due to enzyme deficiencies, is a significant driver for market expansion. For instance, MPS I and MPS VI saw 3.62 births per 100,000 live births, highlighting the need for effective treatment solutions to manage symptoms and prevent complications.
Explore the global mucopolysaccharidosis treatment market with a detailed sample report: https://www.thebusinessresearchcompany.com/sample_request?id=11942&type=smp
Key Players and Market Trends
Major companies such as Pfizer Inc., Johnson & Johnson, and Roche Holding AG are focusing on cell therapies and gene editing technologies to sustain their market positions. Immusoft's ISP-001, an engineered B cell therapy for MPS I, received FDA clearance for its Investigational New Drug (IND) application, marking a significant milestone in the treatment landscape.
Segments of the Mucopolysaccharidosis Treatment Market
• Treatment Types: Enzyme Replacement Therapy, Stem Cell Therapy
• Diseases Covered: MPS I, MPS II, MPS IV, MPS VI, Other Diseases
• Routes of Administration: Intravenous, Intracerebroventricular
• End-User: Hospitals, Specialty Clinics, Other End-Users
Geographical Insights: North America Leads the Market
North America emerged as the largest region in the mucopolysaccharidosis treatment market in 2023, driven by advanced healthcare infrastructure and high awareness levels. The report provides comprehensive insights into regional dynamics, market trends, and growth opportunities.
Order your report now for swift delivery: https://www.thebusinessresearchcompany.com/report/mucopolysaccharidosis-treatment-global-market-report
Mucopolysaccharidosis Treatment Global Market Report2 2024 from TBRC covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Trends, opportunities, strategies and so much more.
The Mucopolysaccharidosis Treatment Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on mucopolysaccharidosis treatment market size3, mucopolysaccharidosis treatment market drivers and trends, mucopolysaccharidosis treatment market major players, competitors' revenues, market positioning, and market growth across geographies. The mucopolysaccharidosis treatment market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.
Browse Through More Similar Reports By The Business Research Company:1
Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/benign-prostatic-hyperplasia-bph-treatment-devices-and-equipment-global-market-report
Urinary Stone Treatment Devices And Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/urinary-stone-treatment-devices-and-equipment-global-market-report
Peripheral Vascular Devices And Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/peripheral-vascular-devices-and-equipment-global-market-report
About The Business Research Company
The Business Research Company has published over 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.
Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn
1 https://www.thebusinessresearchcompany.com/
2 https://www.thebusinessresearchcompany.com/report/mucopolysaccharidosis-treatment-global-market-report
3 https://www.thebusinessresearchcompany.com/report/mucopolysaccharidosis-treatment-global-market-report
